VP candidate stokes misleading claims about fentanyl-laced marijuana
A New York representative shares concerns about carfentanil, and the DEA warns about xylazine.
The latest
Health care providers are prepared to talk to their patients about fall vaccines, but may underestimate COVID-19 risk
We surveyed 246 health care providers in August 2024, just before the FDA approved updated COVID-19 vaccines. Here’s what we learned.
Full story
Our partners
Get started with these essential resources
Real-time dashboards
Real-time intelligence on the health narratives trending nationally, regionally, and by state.
Weekly insights
Contextualizing trending narratives across the nation's most pressing health topics.
Actionable trainings
The first U.S.-based trainings on infodemiology for public health professionals and health care providers.
JMIR FEED
The first and only peer-reviewed journal focusing on infodemiology
Featured trainings and resources
